(Q36065990)

12 August 2017

1 reference

title

Cilansetron: a new serotonergic agent for the irritable bowel syndrome with diarrhoea (English)

1 reference

12 August 2017

0 references

irritable bowel syndrome

1 reference

William D Chey

1

1 reference

12 August 2017

Brooks D Cash

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

published in

1 reference

12 August 2017

volume

14

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

185-193

1 reference

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.2.185

Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.2.185

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.2.185

Effects of the 5-HT3 antagonist cilansetron vs placebo on phasic sigmoid colonic motility in healthy man: a double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.2.185

Occurrence of colon ischemia in relation to irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.2.185

Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.14.2.185

10.1517/13543784.14.2.185

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference